Broad-spectrum Antivirals Against 3C or 3C-like Proteases of Picornaviruses, Noroviruses, and Coronaviruses
Overview
Authors
Affiliations
Phylogenetic analysis has demonstrated that some positive-sense RNA viruses can be classified into the picornavirus-like supercluster, which includes picornaviruses, caliciviruses, and coronaviruses. These viruses possess 3C or 3C-like proteases (3Cpro or 3CLpro, respectively), which contain a typical chymotrypsin-like fold and a catalytic triad (or dyad) with a Cys residue as a nucleophile. The conserved key sites of 3Cpro or 3CLpro may serve as attractive targets for the design of broad-spectrum antivirals for multiple viruses in the supercluster. We previously reported the structure-based design and synthesis of potent protease inhibitors of Norwalk virus (NV), a member of the Caliciviridae family. We report herein the broad-spectrum antiviral activities of three compounds possessing a common dipeptidyl residue with different warheads, i.e., an aldehyde (GC373), a bisulfite adduct (GC376), and an α-ketoamide (GC375), against viruses that belong to the supercluster. All compounds were highly effective against the majority of tested viruses, with half-maximal inhibitory concentrations in the high nanomolar or low micromolar range in enzyme- and/or cell-based assays and with high therapeutic indices. We also report the high-resolution X-ray cocrystal structures of NV 3CLpro-, poliovirus 3Cpro-, and transmissible gastroenteritis virus 3CLpro- GC376 inhibitor complexes, which show the compound covalently bound to a nucleophilic Cys residue in the catalytic site of the corresponding protease. We conclude that these compounds have the potential to be developed as antiviral therapeutics aimed at a single virus or multiple viruses in the picornavirus-like supercluster by targeting 3Cpro or 3CLpro.
Dias-Solange D, Le M, Gottipati K, Choi K Sci Adv. 2025; 11(11):eads6862.
PMID: 40073119 PMC: 11900867. DOI: 10.1126/sciadv.ads6862.
Sescil J, Fiel H, Havens S, Fu E, Li X, Kroning K RSC Chem Biol. 2025; .
PMID: 39975583 PMC: 11835013. DOI: 10.1039/d4cb00276h.
Advancements in the development of antivirals against SARS-Coronavirus.
Kumar M, Baig M, Bhardwaj K Front Cell Infect Microbiol. 2025; 15:1520811.
PMID: 39917633 PMC: 11798951. DOI: 10.3389/fcimb.2025.1520811.
Jiang Z, Piao L, Ren C, Zhang W, Zhu Y, Kong R ACS Omega. 2025; 10(2):2092-2101.
PMID: 39866606 PMC: 11755153. DOI: 10.1021/acsomega.4c08601.
Structural Analysis of Inhibitor Binding to Enterovirus-D68 3C Protease.
Azzolino V, Shaqra A, Ali A, Yilmaz N, Schiffer C Viruses. 2025; 17(1).
PMID: 39861864 PMC: 11768739. DOI: 10.3390/v17010075.